Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT02977442 |
Other study ID # |
PBRC 2018-020 |
Secondary ID |
|
Status |
Active, not recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
November 2016 |
Est. completion date |
December 2024 |
Study information
Verified date |
June 2024 |
Source |
Pennington Biomedical Research Center |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Insulin promotes the clearance of sugars from the blood into skeletal muscle and fat cells
for use as energy; it also promotes storage of excess nutrients as fat. Type 2 diabetes
occurs when the cells of the body become resistant to the effects of insulin, and this causes
high blood sugar and contributes to a build-up of fat in muscle, pancreas, liver, and the
heart. Understanding how insulin resistance occurs will pave the way for new therapies aimed
at preventing and treating type 2 diabetes.
Mitochondria are cellular structures that are responsible for turning nutrients from food,
into the energy that our cells run on. As a result, mitochondria are known as "the powerhouse
of the cell." Mitochondria are dynamic organelles that can move within a cell to the areas
where they are needed, and can fuse together to form large, string-like, tubular networks or
divide into small spherical structures. The name of this process is "mitochondrial dynamics"
and the process keeps the cells healthy. However, when more food is consumed compared to the
amount of energy burned, mitochondria may become overloaded and dysfunctional resulting in a
leak of partially metabolized nutrients that can interfere with the ability of insulin to
communicate within the cell. This may be a way for the cells to prevent further uptake of
nutrients until the current supply has been exhausted. However, long term overload of the
mitochondria may cause blood sugar levels to rise and lead to the development of type 2
diabetes.
This study will provide information about the relationship between mitochondrial dynamics,
insulin resistance and type 2 diabetes.
Description:
The traditional view of mitochondria as isolated, spherical, energy producing organelles is
undergoing a revolutionary transformation. Emerging data show that mitochondria form a
dynamic networked reticulum that is regulated by cycles of fission and fusion. The discovery
of a number of proteins that regulate these activities has led to important advances in
understanding human disease. Data show that activation of dynamin related protein 1 (Drp1), a
protein that controls mitochondrial fission, is reduced following exercise in prediabetes,
and the decrease is linked to increased insulin sensitivity and fat oxidation. The proposed
research will test the hypothesis that mitochondrial dynamics is a key mechanism of insulin
resistance in type 2 diabetes. The experimental approach harnesses innovative molecular and
cellular tools, interfaced with physiologically significant human studies to obtain
meaningful data on insulin resistance, and has the potential to generate insights that will
lead to new diabetes therapies for future generations.